Proteomics International Laboratories Enters into a National Distribution Agreement with Healius
Get your Free Report on Top 5 ASX stocks for 2025
Proteomics International Laboratories Limited (ASX: PIQ) has announced on 22 July 2026 a national Australian distribution agreement appointing Healius Limited (ASX: HLS) as exclusive pathology distribution partner for its Promarker portfolio. This will establish the Companyβs first national commercial distribution pathway for the tests. Β
Healius will use its national pathology infrastructure and more than 2,000 collection centres to support specimen collection, distribution and market access. Proteomics International will perform all Promarker testing through its accredited laboratories and provide clinical reporting, scientific support and regulatory oversight. Β
The arrangement is intended to deliver capital efficient commercial implementation by leveraging Healius referrer relationships with general practitioners, specialists and hospitals rather than requiring Proteomics International to build its own collection network.
The parties will work collaboratively on implementation and commercial rollout with each organisation focusing on its respective areas of expertise as the Promarker portfolio moves through its early commercialisation phase. Β
The agreement sets Proteomics Internationalβs preferred Australian commercialisation model for the portfolio and creates a scalable distribution pathway for national access although potential revenue from the partnership cannot yet be reliably estimated and commercial terms remain confidential.Β
Implementation activities including operational and IT integration, workflow changes and clinician engagement are scheduled to commence immediately with phased commercial rollout of the Promarker tests planned to begin progressively during FY27. Β
(Source: Company Announcement)
Disclaimer
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether itβs appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
Feature News
Checkout Our Recommendation for free - 7 days free trial
Start Free TrialRecent News
Change Financial Limited, Building on its Maiden U..
Fletcher Building Receives Govt Support to Secure ..
Perseus Mining Pursuing Value Creating Organic Gro..
Centaurus Metals Secures Approval for High-Voltage..
Synertec Corporation Executes Contracts with Santo..